Absorption |
Blood-Brain Barrier | BBB+ | 0.9639 |
Human Intestinal Absorption | HIA+ | 0.9648 |
Caco-2 Permeability | Caco2+ | 0.7935 |
P-glycoprotein Substrate | Substrate | 0.8989 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.7303 |
Non-inhibitor | 0.9274 |
Renal Organic Cation Transporter | Inhibitor | 0.5087 |
Distribution |
Subcellular localization | Mitochondria | 0.5142 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.7879 |
CYP450 2D6 Substrate | Substrate | 0.7960 |
CYP450 3A4 Substrate | Substrate | 0.7756 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.7790 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8779 |
CYP450 2D6 Inhibitor | Inhibitor | 0.5085 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.8090 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.8708 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7681 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9486 |
Non-inhibitor | 0.8902 |
AMES Toxicity | Non AMES toxic | 0.8838 |
Carcinogens | Non-carcinogens | 0.9614 |
Fish Toxicity | High FHMT | 0.9732 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9526 |
Honey Bee Toxicity | Low HBT | 0.5184 |
Biodegradation | Not ready biodegradable | 0.9816 |
Acute Oral Toxicity | III | 0.5696 |
Carcinogenicity (Three-class) | Non-required | 0.6423 |